Solid debut for Ocumension and SmooreBusiness | 10 Jul 2020 7:54 pm
Shares in Ocumension Therapeutics (1477) and Smoore International (6969) both surged by 1.5 times on debut today in Hong. Kong.
Loss-making biotech firm Ocumension, which received nearly 1,895 times oversubscription for its retail tranche, once gained by 1.9 times before paring gains, closing at HK$37 today, representing a gain of HK$11,170 for a board lot.
Immunotech Biopharm (6978) surged by 41 percent to HK$15.48, a gain of HK$4,480 per lot.
Investors of e-cigarette maker Smoore booked HK$18,600 per lot after it closed at HK$31. Shares of property management company Zhenro Services (6958) also climbed by 23 percent to HK$5.60.